Prospect Capital Corporation (PSEC) insider have most recently took part in a trading activity. On Nov 24, 2017 Barry John F, CHIEF EXECUTIVE OFFICER, 10% Owner bought 279,666 shares having total worth of $1,907,322 at the price of $6.82 per share, following the transaction a total of 26,859,865 shares owned by Barry John F. Before this latest buy, Barry John F purchased PSEC at 4 other times during the past twelve months, for a total investment of $169.18M at an average of $6.58 per share.
The stock has experienced a total of 10 insider trades in the past three months. These trades include 10 buy trades. Furthermore, over the past 12 months , the stock was traded 17 times by insiders. an employee of the company was the buyer in 17 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Prospect Capital Corporation (PSEC) traded up 0.44% on Nov 27, 2017, hitting $6.83. 2,402,470 shares of the company’s stock traded hands. Prospect Capital Corporation has a 52 week low of $5.56 and a 52 week high of $9.53. The company’s market cap is $2,950 million.
Prospect Capital Corporation (PSEC) last announced its earnings results on Nov 8, 2017. The company reported 0.18 earnings per share (EPS) for the quarter, lower than the consensus estimate of 0.19 by $0.01. The company had revenue of $159 million for the quarter, compared to the consensus estimate of $166 million. During the same quarter in the previous year, the company posted 0.22 earnings per share. The company’s revenue for the quarter was down 12% on a year-over-year basis.
|earnings per share||0.18||0.19||0.20||0.24||0.22||0.25||0.25||0.28||0.26||0.26|
Prospect Capital Corporation was incorporated in the State of Maryland. The Company provides capital to middle-market companies and private equity financial sponsors for refinancing, leveraged buyouts, acquisitions, recapitalizations, later-stage growth investments, and capital expenditures. It invests in senior and subordinated debt and equity of companies in need of capital for acquisitions, divestitures, growth, development and recapitalization. The Company currently has seven origination strategies in which it makes investments: lending in private equity sponsored transactions, lending directly to companies not owned by private equity firms, control investments in corporate operating companies, control investments in financial companies, investments in structured credit, real estate investments and investments in syndicated debt. The Company’s investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. It seeks to maximize returns and protect risk for its investors by applying rigorous credit analysis to make and monitor its investments.
Latest posts by William White (see all)
- Insider Trading Activity in: Second Sight Medical Products, Inc. $EYES - July 19, 2018
- Insider Trading Activity in: Internationa Flavors & Fragrances, Inc. $IFF - July 19, 2018
- Insider Trading Update: Opko Health, Inc. $OPK - July 19, 2018